AFT Pharmaceuticals are a growing multinational pharmaceutical company that develops, markets and distributes a broad portfolio of pharmaceutical products across a wide range of therapeutic categories which are distributed across all major pharmaceutical distribution channels: over-the-counter, prescription and hospital.
AFT’s product portfolio comprises both proprietary and in-licensed products, and includes patented, branded and generic drugs.
AFT on the Share Market
Below are links to NZX and ASX, discover our share price on your respective platform
Results and Announcements
February 7, 2024
Maxigesic IV launched in the United States
AFT Pharmaceuticals announces Maxigesic IV®, the patented intravenous form of its family of pain relief medicines, has today been launched in the US …
Frequently asked questions
To invest in AFT Pharmaceuticals please contact your usual stockbroker. In most stock tracking software you can use the symbol AFT (NZSX). A full list of New Zealand stockbrokers and other information about buying or selling shares on the NZX can be found on the NZX website.
To invest in AFT Pharmaceuticals please contact your usual Stockbroker. In most stock tracking software you can use the symbol AFP. If you do not have a Stockbroker A full list of Australian Stockbrokers and other information about buying or selling shares on ASX can be found on the ASX website.
AFT Pharmaceuticals Ltd. shares can generally only be purchased through an NZX or ASX registered share broker. However, you can contact your local share broker to see if they have a relationship with an NZX or ASX registered broker.
Computer Share manages AFT Pharmaceuticals share register. Computer Share can be contacted by emailing enquiry@computershare.co.nz or phoning +64 9 488 8700.